Fat Embolism Syndrome in Duchenne Muscular Dystrophy Patients: Early Recognition and Aggressive Therapy by Murphy, Lee D. et al.
Case Report
Fat Embolism Syndrome in Duchenne Muscular Dystrophy
Patients: Early Recognition and Aggressive Therapy
Lee D. Murphy ,1 Mouhammad Yabrodi,1,2 and Riad Lutfi1
1Division of Pediatric Critical CareMedicine, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA
2Division of Pediatric Cardiology, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA
Correspondence should be addressed to Lee D. Murphy; ledmurph@iu.edu
Received 8 March 2018; Revised 28 April 2018; Accepted 30 April 2018; Published 4 June 2018
Academic Editor: Chiara Lazzeri
Copyright © 2018 Lee D. Murphy et al.This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
We describe two pediatric patients with Duchenne muscular dystrophy that presented with acute neurologic deterioration and
hypoxic respiratory failure requiring mechanical ventilation. These cases fulfill the clinical criteria for Fat Embolism Syndrome.
Early recognition and aggressive supportive therapy with mechanical ventilation, right ventricular afterload reduction, and blood
transfusion led to survival without any residual effects from the event. Fat Embolism Syndrome needs to be considered early in the
course of patients with Duchenne muscular dystrophy who present with respiratory and neurological symptoms.
1. Introduction
Duchenne muscular dystrophy (DMD) is the most common
inherited pediatric muscle disorder affecting approximately
1 in 3600 live male births [1]. Patients with DMD have a
significant reduction in bone density due to chronic use of
steroids, which results in increased incidence of long bone
fractures and the potential development of Fat Embolism
Syndrome (FES) [2]. When children with DMD present
with altered mental status and respiratory compromise, the
physician needs to consider FES in the differential diagnosis.
We report two cases of pediatric patients with DMD that
presented to the emergency department with altered mental
status and respiratory compromise that were diagnosed with
FES. Due to early recognition of the disease and aggressive
supportive care withmechanical ventilation, right ventricular
afterload reduction, and blood transfusion, both patients
survived without any significant sequelae.
2. Case Report
2.1. Case 1. A 14-year-old male with DMD has been on daily
oral steroid since 9 years of age. He weighed 53 kg (47th
percentile) and was 147 cm tall (less than 3rd percentile).
He became nonambulatory at 12 years of age. Forced vital
capacity (FVC) was 2.37 L or 80% predicted. A polysomno-
gramwas completed and revealedmoderate obstructive sleep
apnea.His echocardiogram (ECHO)was normalwith cardiac
magnetic resonance imaging (MRI) demonstrating normal
left ventricular ejection fraction (LVEF). He participated in
many school activities including wheelchair soccer.
He presented to the emergency department with confu-
sion, tachycardia, tachypnea, and fever up to 39.2 degrees Cel-
sius a few hours following soccer practice. During practice,
he had been transferred from his wheelchair and his right leg
had brushed the ground causing him to have to be placed on
the ground until more help was obtained to put him back
in his wheelchair. Brain computed tomography (CT) was
negative for any acute intracranial process contributing to
his current state. Chest computed tomography (CT) scan was
negative for pulmonary embolism but showed patchy diffuse
nodular airspace opacities seen scattered throughout both
lung fields (Figure 1(a)). He had progressive acute hypoxic
respiratory failure requiring mechanical ventilation. Shortly
after intubation, he suffered cardiac arrest requiring 3 min-
utes of cardiopulmonary resuscitation (CPR) before return
of spontaneous circulation. ECHOs were consistent with
increased pulmonary vascular resistance including moderate
right ventricle dysfunction and elevated pulmonary arterial
pressure. Duplex ultrasound evaluation of lower extremities
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(a) Patchy diffuse nodular airspace opacities seen scattered
throughout both lung fields
(b) Nondisplaced fracture at the distal right tibial metaphysis and
fibular metaphysis
Figure 1
was without evidence of deep venous thrombosis bilaterally.
X-rays of lower extremities revealed cortical step off at
the proximal left femoral neck and nondisplaced fracture
at the distal right tibial metaphysis and fibular metaphysis
(Figure 1(b)). Ophthalmologic exam revealed Purtscher-like
retinopathy. The patient was treated with 48 hours of antibi-
otics that were discontinued with negative blood, urine, and
mini bronchoalveolar lavage (BAL) culture. The patient was
treated with mechanical ventilation and right ventricular
afterload reduction with milrinone and inhaled nitric oxide
for pulmonary hypertension. These therapies were able to be
weaned off, and the patient was able to be extubated on day
five of admission. He was later transferred to the pediatric
floor and later discharged home without any residual effects
from the entire event.
2.2. Case 2. An 11-year-oldmale with DMDhas been on daily
oral steroid since 9 years of age. He weighed 30 kg (5.6th
percentile) and he was 120 cm tall (less than 3rd percentile).
He is able to ambulate without assistance. FVC was 1.5 L
or 96% predicted. His ECHO was normal with cardiac MRI
demonstrating normal LVEF.
(a) Nondisplaced Salter-Harris type II fracture of the distal
left femur
(b) Patchy diffuse nodular airspace opacities seen scattered
throughout both lung fields
Figure 2
He sustained a nondisplaced Salter-Harris type II frac-
ture of the distal left femur (Figure 2(a)) from a fall that
required surgical fixation and was able to be discharged
home on the day of operation. He presented to the emer-
gency department two days after his operation with seizure,
tachycardia, tachypnea, and fever up to 38.6 degrees Cel-
sius. He had progressive acute hypoxic respiratory failure
requiring mechanical ventilation. Shortly after intubation,
he developed pulmonary hemorrhage and anemia remedied
with fresh frozen plasma, ventilator adjustments, and blood
transfusion. A fast spin MRI of his head was negative. CT
scan of his chest demonstrated bilateral patchy infiltrates;
no pulmonary embolism was identified (Figure 2(b)). ECHO
revealed mildly elevated tricuspid regurgitation velocities
representing increased right ventricular and pulmonary
artery pressures. He was placed on broad spectrum antibi-
otics for 72 hours but blood, urine, and mini BAL remained
negative. Mechanical ventilation was able to be weaned
and the patient was extubated on day five of admission.
He was later transferred to the pediatric floor and later
discharged home without any residual effects from the entire
event.
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Table 1: Gurd’s criteria to diagnose fat embolism syndrome.
CASE 1 CASE 2
MAJOR CRITERIA
Petechial Rash Yes No
Respiratory Insufficiency Yes Yes
Cerebral Involvement Yes Yes
MINOR CRITERIA
Tachycardia Yes Yes
Pyrexia Yes Yes
Retinal changes: fat or petechiae Yes No
Jaundice No No
Renal: anuria/oliguria or lipiduria No No
Sudden fall in hemoglobin concentration Yes Yes
SuddenThrombocytopenia No No
High erythrocyte sedimentation Rate Yes Yes
Fat macroglobulinemia No N/A
3. Discussion
The diagnosis of FES is made up of a group of nondescript
symptoms that could represent a multitude of diagnoses [3,
4]. Many cases go unnoticed and therefore the true incidence
of FES is unknown [5]. The pathophysiology is thought
to be a result of fat droplets released from bone marrow,
most commonly after traumatic fractures or orthopedic
procedures [4]. Small fat droplets are released into the venous
circulation. These droplets can either become lodged in the
pulmonary circulation or pass into the systemic circulation
and lodge in the cerebral vasculature causing microinfarcts
[6]. In DMD patients, FES is increasingly becoming a well-
recognized complication as patients with this condition are
prone to falls and minor trauma, leading to fractures due to
the use of chronic corticosteroids and prolonged immobility
[1].
Clinical presentation can range from asymptomatic to
cardiac arrest from right ventricular heart failure. Typically,
the onset of symptoms happens within the first 12–24 hours
after trauma, although some cases may occur as late as
36–72 hours [5, 6]. There are no standardized, prospectively
validated diagnostic criteria for FES.Thediagnosis ismade by
recognizing the characteristic clinical syndrome in the con-
text of supportive imaging and a predisposing insult. Given
the absence of a gold-standard diagnostic test, a number of
authors have proposed clinical diagnostic criteria. The most
frequently cited, despite low sensitivity and specificity, are
Gurd’s criteria (Table 1). Gurd’s criteria have been adapted
over the years to include the following variations: 1 major
with 4 minor or 2 major and 2 minor are the most commonly
used definition to diagnose FES [7]. Major criteria include
respiratory failure, neurologic changes, and a petechial rash
[6, 7].
The lungs are usually the most affected organs with
rapidly progressing tachypnea and hypoxemia as the primary
clinical symptoms [3, 6]. Chest X-ray shows a diffuse bilateral
infiltrate that is hard to differentiate from pediatric acute
respiratory distress syndrome. Chest computed tomography
(CT) does not add much to a regular chest x-ray in terms of
diagnosis; however, it is usually done to rule out pulmonary
embolism. Alveolar hemorrhage can be also seen in FES [8].
The brain is the secondmost affected organ. Neurological
symptoms are extremely variable between irritability, anxiety,
agitation, confusion, delirium, convulsions and coma, and
hypertonia. Cerebral CT scan is usually negative. MRI with
DWI is a more specific diagnostic modality [6, 9].
Skin petechiae represent the third most important sign
for clinical diagnosis. These tiny lesions (1-2 mm) are, in fact,
small hemorrhages caused by the rupture of skin capillaries.
The time elapsed from trauma to petechial onset varies with
their location but the typical pattern is found in the axillary
and high presternal region, in lateral surfaces of the neck, and
in eye conjunctiva [5].
In addition to lungs, brain, skin, and conjunctivas,
there are minor criteria that include tachycardia, fever,
retinal changes, anuria or oliguria, sudden hematocrit and/or
platelets drop, and positive fat on sputum [3]. Some patients
will develop acute pulmonary hypertension and subsequent
acute right heart failure and cardiovascular collapse. Using
right ventricular afterload reduction with milrinone and/or
inhaled nitric oxide may be beneficial in this setting [10, 11].
A recent systematic review specifically looking at the few
published case reports about Fat Embolism Syndrome in
childrenwithDuchennemuscular dystrophy found that 7 out
of the 16 (44%) children died [12]. In our paper, we report two
cases of FES with favorable outcomes. Early recognition and
aggressive supportive treatment are key elements for good
outcomes in this fragile population. Anticipating potential
complications such as anemia, thrombocytopenia, right ven-
tricular failure, or acute kidney injury is another key of the
management.
4. Conclusion
Our report highlights the need of high index of suspicion
for FES in the DMD population and the need for aggressive
supportive therapy when these children present with acute
altered mental status and respiratory distress.
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